Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference83 articles.
1. Atif M, Azeem M, Sarwar MR. Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature. Springerplus [Internet]. 2016 25;5:182. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27026878.
2. Yamada M, Welty TE. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies. Ann Pharmacother [Internet]. 2011/10/25. 2011;45(11):1406–15. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22028417.
3. Shaw SJ, Hartman AL. The Controversy over Generic Antiepileptic Drugs. J Pediatr Pharmacol Ther [Internet]. 2010;15(2):81–93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22477799.
4. Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, et al. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard. Epilepsia [Internet]. 2015/07/23. 2015, 56(9):1415–24. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26201987.
5. Bialer M, Midha KK. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability. Epilepsia [Internet]. 2010/04/08. 2010;51(6):941–50. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20384761.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献